Even with all of the turmoil in the healthcare market in 2012, the overall healthcare sector performed well. Drug approvals were positive compared with 2011, procedure volumes stabilized and cost initiatives were realized. These factors, along with consolidation, all supported a more favorable investment environment. As 2012 came to a close, CCC Financial Communications wanted to get a read on investor sentiment in light of several challenges on the horizon which may impact performance. Therefore, we surveyed institutional investors and sell-side analysts in the U.S. about their attitudes toward investing in healthcare markets in 2013. We asked about concerns surrounding implementation of the Affordable Care Act (ACA), key sectors and geographies that offer opportunity, and those areas that may present the greatest risk.
The survey revealed several sectors and geographies where investors see opportunity within the healthcare market, although the post-election outlook leans more negative. With the re-election of President Obama, one-third of investors have no change in their outlook, and more than 45% revealed that their outlook is worse.
On the plus side, although investors had a somewhat mixed outlook for Western Europe, Eastern Europe, U.S. and Japan, they continue to be positive on markets such as China, India and Latin America. Certain healthcare sectors were viewed as having greater potential than others including healthcare information technology, which should benefit from the implementation of ACA, and mid-size and emerging pharmaceutical and biotechnology, which should benefit from positive drug approval trends and more robust mid- and late-stage pipelines.
Overall, investors appear to be cautiously optimistic. But, given the level of uncertainty which appears to have no shortage of new ammunition with the added concerns over deficit reduction, is cautious optimism still too rosy an outlook?
To read the full report, please click here.